By participating in the study, you have the opportunity to take part in industry-independent GP practice-based healthcare research on a highly relevant topic. The improvement of the cooperation between GP practices and pharmacies offers the opportunity for a meaningful division of labour in medication management and the option to relieve GP practices of this task in the future. In addition, you will gain access to further training and tools for the management of multi-medication and can strengthen the cooperation of your GP practice with pharmacies. After completion of the study, we will present the results to you.

For GPs: In the intervention, specific GP activities such as medication review, adjustment and coordination with patients are used and supported with newly developed information and tools. This support helps to give you more decision-making confidence and therefore tends to reduce your professional risks in dealing with multi-medication.

For pharmacists: Participation in the study does not involve any risks for yourself. It may be that the GP decides to change the medication in consultation with the patient during the study. However, all clinical decisions (including all medication changes) are at the discretion of the GP, require the patient's consent and are not determined by the study protocol. In the event of adverse effects, medication changes may be reversed at the discretion of the GP and in consultation with the patient.

If you are assigned to the control group, both GP practices and pharmacies will each receive an expense allowance of EUR 120 per included patient. If you are assigned to the PARTNER intervention group, you will receive an expense allowance of EUR 180 per included patient.